Blending science and technology, the innovation makes toxicity testing faster, fairer, and more reliable.
In
a pioneering step for laboratory automation and ethical toxicology, a team of
Indian researchers has developed an Automated Analysis Device for the Isolated
Chicken Eye (ICE) Test, offering a faster, more accurate, and humane
alternative for assessing ocular irritation. The innovation, developed under SwaLife
Biotech Pvt. Ltd., brings digital intelligence and algorithmic precision to a
globally recognized model for eye irritation testing.
The
project was conceptualized and led by Dr. Pravin Dattatraya Badhe and Dr.
Ashwini Pravin Badhe, founders and directors of SwaLife Biotech. They were
joined by collaborators Dr. Trupti Deshpande, Dr. Vaishali Amar Patil, and
Prof. Prashant Damodar Mali, all experts in pharmacology, toxicology, and life
sciences. Together, this multidisciplinary team envisioned a solution that
merges biological testing expertise with digital automation, setting new
benchmarks in non-animal research innovation.
The
innovation has now been officially published and recognized as a registered
design, marking a key milestone in SwaLife Biotech’s journey toward developing
advanced, ethical testing technologies.
A
Smarter Way to Conduct Ocular Toxicity Testing
The
Isolated Chicken Eye (ICE) Test is a trusted non-animal method for assessing
eye irritation caused by chemicals or formulations. Traditionally, it depends
on manual observation of corneal opacity, swelling, and surface damage a
process that can be slow and subjective.
SwaLife
Biotech’s Automated ICE Test Analysis Tool transforms this workflow with a
web-based, algorithm-driven system. Researchers can upload corneal images,
which the software analyzes to measure optical density, surface changes, and
tissue damage with precision. It also allows batch processing, enabling faster,
more consistent, and reproducible results across multiple samples.
Innovation
Rooted in Science and Ethics
The
innovators behind this development share a common goal: to reduce human bias
and promote data-driven, ethical toxicology.
By
digitizing the ICE Test, the system supports the 3Rs principle Replacement,
Reduction, and Refinement which guides global efforts to minimize animal
testing. The tool aligns with OECD Test No. 438 guidelines, making it
compatible with internationally accepted toxicological frameworks.
With
its intuitive interface and analytical precision, this innovation provides
laboratories, academic institutes, and regulatory research centers with a
powerful tool for non-animal, evidence-based toxicity testing.
Advantages
of the Automated ICE Test Analysis Tool
This
innovation brings several key benefits it delivers objective, bias-free
analysis, processes multiple samples quickly, and ensures consistent,
quantifiable results that meet OECD standards. It also improves efficiency,
transparency, and promotes ethical, non-animal testing. Together, these
strengths make it a practical and reliable tool for pharmaceutical, cosmetic,
and chemical labs focused on safe and responsible research.
SwaLife
Biotech: Fusing Technology and Life Sciences
Based
in Pune, SwaLife Biotech Pvt. Ltd. is a growing Indian biotechnology company
focused on science-backed, technology-driven health and research solutions. Its
HealthTech division develops AI-assisted and automated systems that improve
accuracy and efficiency in biological research.
Through
innovations like the ICE Test Analysis Tool, SwaLife Biotech continues to merge
biotechnology, digital analytics, and ethics for smarter and more sustainable
science. Its PureHerbs Capsules line featuring Tulsi, Neem, Turmeric, Moringa,
and Wheatgrass reflects the company’s holistic vision of blending traditional
wisdom with modern innovation.
A
Step Toward Responsible Science
The
Automated ICE Test Analysis Tool exemplifies how Indian innovators are leading
a new era of ethical and intelligent biotechnology. By bringing automation and
compassion into the same framework, Dr. Pravin Badhe and his team have set a
new benchmark in non-animal, high-precision testing technologies.
As
global research moves toward sustainability and transparency, SwaLife Biotech’s
innovation stands as a testament to how technology, empathy, and scientific
rigor can coexist reshaping the future of responsible toxicology and modern
laboratory science.
Call
to Action
To
learn more, visit https://swalifebiotech.com
or email info@swalifebiotech.com